End of Presale and the Start of a New Adventure: Happy Holidays

2018 has literally been a rollercoaster for Aimedis. Conferences, pitches, events, teamwork to make the dream work. We would like to thank each and every one of you who contributed to where we are today: a running product, in use across 20 hospitals in 4 countries (Europe and Asia).

Presale has ended a few weeks ago, as we announced on our social media channels and in our Telegram community.  We have learned valuable lessons, especially with the crypto market crash. There is no date set for the crowd sale yet.

Thoughts of 2019…

Christmas and New Year’s are a great time to step away from the daily habits and just indulge yourself in quality time with family, friends, loved ones.

To be grateful, and to cherish what the past 12 months have given you. To celebrate and to look forward to the new year. The team will take a break to recharge and prepare for the upcoming steps in our roadmap.


For 2019, we’d like to focus on the development of Aimedis 2.0 and AIMchain, and bring the product and its functionalities into more hospitals, to serve our patients, doctors, and partners (insurance, pharma companies).

Enjoy the winter holidays, wherever you are in the world.

Peace and love,


CCO @ Aimedis

Von |2018-12-23T16:38:30+01:00Dezember 23rd, 2018|General, ICO, Platform|0 Kommentare

Wearables – Friend or Foe?

Wearables – Friend or Foe??

Earlier this week, Apple launched the latest version of the Apple watch.

 This is one of the first mainstream devices available to the public that can carry out ECG tests. Obviously there is the ability to detect heart conditions such as arrhythmic beating and low heart rates.

This exciting development is a real indication of our need and demand for wearable devices such as this. The smart health watches have really increased in popularity over a very short space of time.

We are fast becoming a worldwide community for whom healthcare, and taking the responsibility for our own health is now the norm. The days where generations before us were reliant on the family doctor are becoming more distant, as we now plug into our devices and search for our health solutions online.


But Could There Be A Problem??

This all sounds extremely positive. However, the chair of the Royal College of Surgeons Commission on The Future of Surgery has warned us of potential problems with our technological age.


Richard Kerr believes that the influx of health information to patients does have the potential to create problems.

He warns that Doctors and Hospitals will see more patients who may be both “confused and scared” about health information that they have accessed.  Kerr states that “..the NHS will need to be ready to handle an influx of patients with potentially valid concerns about their risk of falling ill in the future.” – as reported in Engineering and Technology.


Essentially this will lead to the “worried well” to be concerned about potential medical issues. Issues that they may not experience for many years.  While prevention is both key and the best solution, we do need to draw a balance between unnecessarily worrying about future possibilities.


So this is essentially, where the technology side of the health industry, and the human side of the industry need to meet!  Wearable technology is a fantastic development in our health care.  We do need to be very careful as to how this technology is used or misused. And it is an issue that Aimedis takes very seriously.


There is always worry about the health industry becoming impersonal. An institution fueled by AI robots with no compassion or concern  for the people who use it.

But ask any medical student studying to become a doctor . Yes it’s factual and sometimes detached. But a lot of study time is spent on how to communicate with patients, how to care and truly make a patient feel at ease.


At the end of the day – we need to ensure there is a balance between the technology, and the human!

The technology is enhanced by the human touch.  Just as the doctors’ work and research is undoubtedly enhanced by the available technology.


It’s an amazing time to be in the healthtech industry, and a challenging time as well.

Von |2018-09-22T21:33:27+02:00September 22nd, 2018|General, News|0 Kommentare

Aerosols – Are They Back for Good

Aerosols – Are They Back for Good?

Let’s face it – aerosols have got quite a bad reputation in our culture at the moment.

After their use in abundance during the ‘80’s (remember that hair!), to their bad publicity in the 90’s and their blame in the destruction of the ozone layer with the negative impact on the environment.  It really would take something pretty spectacular to redeem the poor aerosols reputation.

Well, it looks like science may have found just the solution!


A team of researchers from MIT have found a use for aerosols which is not only extremely useful, but beneficial for both our health and the environment.

They have managed to develop a spray which contains nanobots.  These are essentially tiny sensors which can be used for a whole range of tasks – even diagnosing health issues.  Their research was published here in Nature Nanotechnology.


So how does it work?

Each sensor in the spray contains two parts.

The first part is a tiny molecule called a colloid, which can remain in liquid or air indefinitely.

The second part is a complex circuit, which contains a chemical detector, and can also produce its own power needed to collect data.

Researchers have managed to graft these two parts together and have converted them into a spray form, which we know as an aerosol.


So what does this mean in our day to day life?

Well, it is possible for the engineers to spray the aerosol down a pipeline if they were looking for a breach on the pipelines system for example a crack or hole in the pipe. They can then use the data from the aerosol to exactly pinpoint where there is a problem, such as an encounter with a chemical which should not be there which would indicate where there is a potential breach in the pipe.

This process would have otherwise required a manual inspection of the exterior of the pipe which could be  time consuming, labor intensive, costly and not to mention physically difficult.

But what does this mean for health?

The MIT team noted that this exact same technology could be used to diagnose health issues. For example – The nanobots could travel along a patient’s digestive tract gathering data, and relaying it to a medical professional. The potential here is that the nanobots would be able to flag up a problem or a potential problem helping to diagnose the patient in the least invasive way possible.


Does this sound like the stuff of dreams?

Well yes it does! But don’t forget that not so long ago, wearable devices such as trackers that we now use daily to monitor blood pressure, heart rate and even sleep patterns were once seen as impossible technological devices, reserved for Hollywood films and science fiction.


At the end of the day, health care and technology are both advancing together at a phenomenal rate. At Aimedis, part of our focus is on harnessing these technologies, and using the technology available through wearable devices to improve patient monitoring and care.

Aerosol nanobots may be here and a part of your routine health care diagnostics sooner than you think!


Von |2018-09-12T22:28:46+02:00September 12th, 2018|General|0 Kommentare

AI in Healthcare: Bedside robots could soon be a reality in hospitals in the UK

Bedside robots could soon be a reality in public hospitals in the UK.

NHS, the body governing the operations of the public hospitals in the UK is considered to deliver one of the best healthcare in the world. About 243 million patients are seen each year by the NHS. According to the latest figures, NHS employs 106,430 doctors; 285,893 nurses and health visitors; 21,597 midwives; 132,673 scientific, and therapeutic and technical staff. However, a lack of funding and a severe shortage of manpower is making this task more and more difficult with each passing day.

AI in healthcare, UK

A report published by the Institute for Public Policy Research (IPPR) in April this year indicates that a wide adoption of AI and Robotics by the NHS can potentially free up £12.5B worth of resources annually, easing the burden on the system. It will help doctors and support attend to other patients while bedside robots take over functions like helping the patients around the ward, conducting digital triage, and even helping them with exercises and nutrition.

In addition, the use of machine learning and AI can help the NHS with the screening of diseases like Diabetic Retinopathy, certain cancers without involving a specialist. Acting on the recommendations, the secretary of state for Health and Social Care, Jeremy Hunt, has announced a review into how the current NHS staff could be trained in AI and robotics.
This is a huge news for the AI community as this signals a wider adoption by a dominant publically funded body.

AI goes beyond just treatment

With an implementation of AI in healthcare in the UK, patients would have a better access to healthcare. Even though the healthcare in the UK is quite good, patients often have to wait to see a doctor. In many cases, an experienced nurse, also known as a Nurse Practitioner sees a patient with a minor ailment. In the UK as well as the USA, NPs can see patients, make a diagnosis and prescribe a treatment.

With the help of AI, both patients, as well as the Healthcare professionals, will have a better interaction, with easier follow up, convenient prescriptions, and support beyond the clinic. When a patient chooses the services of Aimedis, say in the UK, he has an option to get an e-consultation from a doctor for less, without footing the bill of an expensive private consultation. He can choose to share his data – age, diagnosis, treatment given, outcomes, any side effects, impact on his daily activities, data from his health trackers, with researchers. This helps the researchers come up with better treatment recommendations, Pharmaceutical companies to come up with safer medicines with fewer side effects, and doctors with a feedback for their treatment.

Aimedis welcomes this news and hopes to see exciting developments in the use of AI to shape Public Policy

Also, read: Would you accept healthcare advice from a machine?

Von |2018-07-03T15:44:18+02:00Juni 28th, 2018|AI in news, General|0 Kommentare

AI in Healthcare: would you accept healthcare advice from a machine?

A self-thinking robot has always been the theme of science fiction for decades. We came across robot servants and robot armies on TV, in books, in graphic novels. Maybe this futuristic thought led to the idea of a computer that would ‘learn’ as it goes, or maybe scientists were working on it all along, we would never know. However, the more important thing is, AI is here now. And it is changing the world, including healthcare as we speak.

AI in Healthcare

Siri, Alexa, Cortana, Okay Google, all have been a part of our lives for some time now. We all have observed them getting better in understanding us, and anticipating us. The very fact that we have someone plan our routes, play our songs, and even order our groceries for us shows how intertwined our lives have become with AI.

This simple role of an everyday ‘assistant’ goes a long way in healthcare. Imagine having someone checking on you when you are unwell, or asking you to take it slow because your fitness tracker records a high heart rate. People find value in these things and so, there are companies that are built around such apps.

In healthcare, AI has a wide possibility of applications. Ranging from a simple interactive bot to robotic surgeries, AI is taking the centre stage in advanced healthcare delivery. The simplistic idea is to replace human errors, reduce man-hours, and minimise variations in service delivery. With mobile health and Internet-of-things, many gadgets have entered our lives. The adopters of these are mostly millennials, however, older generations are catching up.

Healthcare advise from a machine?

We all have accepted the role of Siris and Alexas in our life. However, how much would we trust AI when it comes to our health?  To answer this, PwC conducted a survey of adults (men and women, 18 and above) from the EMEA. They were asked questions about their acceptance of AI and robotics in healthcare. The survey shows that the acceptance of AI in healthcare is increasing from the point-of-view of the patients. In a survey from EMEA, over 60% individuals between the ages 18 and 34 are comfortable talking to a bot for their healthcare-related questions, while only 11% of respondents from that age group are unwilling to use AI.

The three areas where people are willing to use AI the most are in tracking their fitness, monitoring heart conditions, and taking and testing blood samples. The least favoured areas are fracture reductions, pregnancy monitoring, and delivering a baby.

These results might be extrapolated to most of the countries in the world. With an increase in adoption of smartphones and m-health, more data points are collected. With the help of adaptive learning, the services of companies offering these apps are becoming better and more accurate, in turn driving up the adoption.

To sum the results up, people are okay with letting the machines advise on diagnostics and fitness. However, they are not so keen yet to let the machines actually operate on them, or even fix their broken bones.

Aimedis: AI in Healthcare reimagined

At Aimedis, we are passionate about technology, particularly the use of AI in Healthcare. With doctors at the core of the company, we foresee huge applications of AI in healthcare and are already integrating AI with blockchain, making way for an easy to use service that will benefit each stakeholder in healthcare – patients, doctors, hospitals, Pharmaceuticals, and insurance companies.

AIM, the Etherium-based tokens fuel the services for Aimedis. They can be used to subscribing to services, exchanging data, or even exchanging information. The Pre-sale of AIM tokens is going to end soon, so get your 25% bonus today!

Also, read: Diagnostics without doctors: Is this the future?

Von |2018-07-07T23:07:49+02:00Juni 26th, 2018|General|0 Kommentare

Diagnostics without doctors: Is this the future?

When we think about a pathologist, we quickly imagine a person wearing thick glasses and a lab coat, peering in a microscope. There is a tray of slides nearby to be checked, and the wall is lined with chemical reagents for the tests. 

However, this picture is changing rapidly. While the slides and the microscope remain more or less constant, most of the diagnostic work is done using advanced machinery. There are easy to use test kits and elaborate equipment that can give you a reading with 99.5% accuracy. Even the microscopes can project the image on a huge LED, and pathologists and clinicians can discuss the cases in Multi-disciplinary meetings.

All these exercises create data that is used by the clinicians as well as the pathologists to learn a bit more, reducing error and improving judgement with each passing day. However, the factor of human error always remains, and this is the focus of newer research in the application of Artificial Intelligence in diagnostic medicine.

The new age of AI in diagnostics

Many companies are investing heavily in creating easy-to-use, almost bedside diagnostic test kits. These would reduce the need for an elaborate lab testing, making screening easier and more practical. Screening is when a lot of samples are tested using simpler test kits, and the ones with red flags are then referred for elaborate lab tests.

Till now, however, these test kits could not remove the factor of human error. An incorrectly obtained sample is not going to test correctly, and a disease can be missed. Using AI, some of these tests are becoming easier to administer.

Talking about screening, in April 2018, The USFDA gave an approval to market the first machine to use AI in diagnostics for detecting Diabetic Retinopathy. It is a condition of the eye where Diabetes can cause blindness.

There were 422 million adults living with Diabetes in 2014. In Europe, the percentage of Diabetes ranges from just under 7% in the UK to over 11% in Germany, over 13% in Portugal, and over 14% in Turkey. and an early diagnosis can prevent that. These countries often spend thousands of Euros per patient on their diabetes programmes. The good news is, diabetic retinopathy can be detected early and prevented. The problem is, many diabetics don’t see an eye specialist on a regular basis, and when they do, it is often too late!

The beauty of this device is that it does not require a specialist to read the results. The images are obtained by a trained technician or a doctor and are interpreted by a software using data points already gathered from a lot of testing. This opens doors for screening procedures that will become less dependent on a particular person, like a specialist, and are easily replicable with minimal training. USFDA hints that there might be quite a few similar machines in the world of diagnostic screening on their way.

Aimedis and AI in diagnostics

Aimedis believes that technology and AI can revolutionise how healthcare is delivered. We have special services where hospitals can use our services to communicate with each other as well as the patients in a better way. Patients with chronic diseases like Diabetes can get online consultations without actually visiting a doctor.

Patients have started using smart blood glucometers now. This allows them to test and store their blood sugar levels with ease. Aimedis integrates this data and a doctor can see it alongside other lab tests and the data from any other trackers easily. This ensures that nothing is lost because there are too many apps to check.

And when a patient suffering from Diabetes needs to Talk to someone who is going through similar pain, we make it possible with our social support function. Support is a very important part of the recovery process. We believe that sharing stories gives you the inner strength to stick to the diet and take your medicines on time, something even the doctor cannot ensure.

We believe that healthcare can benefit massively from the use of AI, and In our own way, we are trying to make it better.

Also, read: Pfizer partnership: a great opportunity for Team Aimedis

Von |2018-07-07T23:05:09+02:00Juni 26th, 2018|General|0 Kommentare